1. Home
  2. ANIX vs HGBL Comparison

ANIX vs HGBL Comparison

Compare ANIX & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIX
  • HGBL
  • Stock Information
  • Founded
  • ANIX 1982
  • HGBL N/A
  • Country
  • ANIX United States
  • HGBL United States
  • Employees
  • ANIX N/A
  • HGBL N/A
  • Industry
  • ANIX Biotechnology: Pharmaceutical Preparations
  • HGBL Business Services
  • Sector
  • ANIX Health Care
  • HGBL Consumer Discretionary
  • Exchange
  • ANIX Nasdaq
  • HGBL Nasdaq
  • Market Cap
  • ANIX 87.1M
  • HGBL 84.0M
  • IPO Year
  • ANIX 1987
  • HGBL N/A
  • Fundamental
  • Price
  • ANIX $3.13
  • HGBL $2.39
  • Analyst Decision
  • ANIX Strong Buy
  • HGBL Strong Buy
  • Analyst Count
  • ANIX 1
  • HGBL 1
  • Target Price
  • ANIX $7.00
  • HGBL $6.00
  • AVG Volume (30 Days)
  • ANIX 70.2K
  • HGBL 45.1K
  • Earning Date
  • ANIX 09-04-2024
  • HGBL 08-08-2024
  • Dividend Yield
  • ANIX N/A
  • HGBL N/A
  • EPS Growth
  • ANIX N/A
  • HGBL N/A
  • EPS
  • ANIX N/A
  • HGBL 0.30
  • Revenue
  • ANIX N/A
  • HGBL $56,094,000.00
  • Revenue This Year
  • ANIX N/A
  • HGBL N/A
  • Revenue Next Year
  • ANIX N/A
  • HGBL $16.83
  • P/E Ratio
  • ANIX N/A
  • HGBL $8.15
  • Revenue Growth
  • ANIX N/A
  • HGBL 3.55
  • 52 Week Low
  • ANIX $2.15
  • HGBL $2.12
  • 52 Week High
  • ANIX $5.13
  • HGBL $3.91
  • Technical
  • Relative Strength Index (RSI)
  • ANIX 65.18
  • HGBL 44.16
  • Support Level
  • ANIX $2.16
  • HGBL $2.51
  • Resistance Level
  • ANIX $3.44
  • HGBL $2.74
  • Average True Range (ATR)
  • ANIX 0.21
  • HGBL 0.10
  • MACD
  • ANIX 0.08
  • HGBL -0.01
  • Stochastic Oscillator
  • ANIX 75.78
  • HGBL 7.89

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a global full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

Share on Social Networks: